Go Pro
OTCMKTS:CVALF

Covalon Technologies Q3 2026 Earnings Report

Covalon Technologies logo
$2.95 -0.25 (-7.70%)
As of 09/29/2026 02:45 PM Eastern

Covalon Technologies EPS Results

Actual EPS
$0.07
Consensus EPS
$0.01
Beat/Miss
Beat by +$0.06
One Year Ago EPS
N/A

Covalon Technologies Revenue Results

Actual Revenue
$7.07 million
Expected Revenue
$6.65 million
Beat/Miss
Beat by +$418.00 thousand
YoY Revenue Growth
N/A

Covalon Technologies Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Covalon Technologies' next earnings date is estimated for Thursday, December 10, 2026, based on past reporting schedules.

Conference Call Resources

Covalon Technologies Earnings Headlines

Covalon Reports Fiscal 2026 Third Quarter Results
Covalon Technologies Ltd CVALF
I've seen this movie before (last time: 17,556%)
My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called to our community before the big move happened… And right now, I'm making my next big call. It's a coin trading under $1.00… one most investors have never even heard of. But the world's largest bank is already building on it. It has a burn mechanism wired directly to institutional usage… meaning the more the big money uses it, the more rare it becomes. And its biggest supply cut in history happened earlier this year…tc pixel
Covalon Reports 2026 Second Quarter Results
See More Covalon Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Covalon Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Covalon Technologies and other key companies, straight to your email.

About Covalon Technologies

Covalon Technologies (OTCMKTS:CVALF) is a Canadian medical technology company focused on developing and commercializing advanced healthcare products. Its activities center on wound care, infection prevention and surgical applications, with technologies designed to help protect tissue, support healing and improve the management of medical procedures.

The company’s product portfolio includes collagen-based wound care products marketed under the ColActive brand, as well as antimicrobial and protective coatings, dressings and other medical devices. Covalon develops technologies for use in hospitals, clinics and other healthcare settings, including products intended to address chronic wounds, surgical wounds and infection-control needs.

Covalon serves healthcare providers and patients through commercial relationships with distributors and medical organizations in North America and selected international markets. The company is headquartered in Canada and has historically operated as a publicly traded healthcare technology business under the Covalon name.

View Covalon Technologies Profile